Connect your AI

CorMedix CRMD Payment Of Contingent Consideration Liabilities Operating Activities

Payment Of Contingent Consideration Liabilities Operating Activities at other companies

Federal SignalFSS

$3.5M—

Orthofix Medical Inc.OFIX

$335K—

The Baldwin Insurance Group, Inc.BWIN

$5.88M-92.5%

StepStone Group Inc.STEP

$0-100%

BlackLineBL

$0—

Limbach Holdings, Inc.LMB

$2.9M+307%

Other financials

Income statement

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept crmd:PaymentOfContingentConsiderationLiabilitiesOperatingActivities.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's payment of contingent consideration liabilities operating activities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CorMedix's payment of contingent consideration liabilities operating activities?: CorMedix (CRMD) reported payment of contingent consideration liabilities operating activities of $220K in Q1 2026.
What does payment of contingent consideration liabilities operating activities mean?: Represents the actual cash outflows made to satisfy obligations arising from business acquisitions, such as performance-based milestones or earn-outs. This metric indicates the realization of acquisition-related liabilities and the actual cash cost of achieving growth targets. It is a critical component for assessing the true cash impact of inorganic growth strategies.